Form 4: Aquestive Therapeutics: Insider Sells Shares for Tax Withholding

Lori J. Braender, Corporate Secretary at Aquestive Therapeutics, reported a transaction involving the withholding of shares to cover tax obligations.

Summary

• Lori J. Braender, Corporate Secretary of Aquestive Therapeutics, Inc., reported a transaction on May 7, 2026.
• This transaction involved the withholding of 135,690 shares of Common Stock.
• The shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Braender beneficially owns 231,042 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard procedural transaction for tax withholding related to executive compensation and does not indicate a change in the insider's fundamental view of the company's prospects.

Negatives

• Insider selling, even for tax purposes, can sometimes be perceived negatively by the market, although this specific transaction is a standard procedure for RSU vesting.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, often related to stock-based compensation vesting and subsequent tax withholding, which is a standard practice in the biopharmaceutical industry.

Stakeholder Impact

• Shareholders: The transaction is a standard tax withholding event and is not expected to have a significant direct impact on the share price. However, any insider selling can be a point of observation for investors.
• Employees: This filing relates to the compensation structure for a specific executive, highlighting the use of RSUs and associated tax implications.
• Management: Demonstrates adherence to SEC reporting requirements for insider transactions.

Key Dates

Keywords

SEC Form 4, Insider Transaction, Aquestive Therapeutics, AQST, Restricted Stock Units, RSU Vesting, Tax Withholding, Beneficial Ownership, Corporate Secretary